Accumulated SET protein up-regulates and interacts with hnRNPK, increasing its binding to nucleic acids, the Bcl-xS repression, and cellular proliferation

Bomsztyk, 2004, HnRNPK: one protein multiple processes, BioEssays, 26, 629, 10.1002/bies.20048 Michelotti, 1996, Heterogeneous nuclear ribonucleoprotein K is a transcription factor, Mol. Cell. Biol., 16, 2350, 10.1128/MCB.16.5.2350 Bomsztyk, 1997, Diverse molecular interactions of the hnRNPK protein, FEBS Lett., 403, 113, 10.1016/S0014-5793(97)00041-0 Habelhah, 2001, ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation, Nat. Cell Biol., 3, 325, 10.1038/35060131 Hsueh, 2011, Aurora-A phosphorylates hnRNPK and disrupts its interaction with p53, FEBS Lett., 585, 2671, 10.1016/j.febslet.2011.07.031 Takimoto, 1993, Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro, J. Biol. Chem., 268, 18249, 10.1016/S0021-9258(17)46837-2 Moumen, 2005, HnRNPK: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage, Cell, 123, 1065, 10.1016/j.cell.2005.09.032 Revil, 2009, Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform, J. Biol. Chem., 284, 21458, 10.1074/jbc.M109.019711 Chen, 2008, Progress in the study of heterogeneous nuclear ribonucleoprotein and its relation with diseases, Sheng Li Ke Xue Jin Zhan, 39, 109 Pino, 2003, Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer, Lung Cancer, 41, 131, 10.1016/S0169-5002(03)00193-4 Roychoudhury, 2007, Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma, Br. J. Cancer, 97, 574, 10.1038/sj.bjc.6603911 Carpenter, 2006, Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer, Br. J. Cancer, 95, 921, 10.1038/sj.bjc.6603349 Mikula, 2010, Comprehensive analysis of the palindromic motif TCTCGCGAGA: a regulatory element of the HNRNPK promoter, DNA Res., 17, 245, 10.1093/dnares/dsq016 Matta, 2009, Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma, Int. J. Cancer, 125, 1398, 10.1002/ijc.24517 Neviani, 2005, The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein, Cancer Cell, 8, 355, 10.1016/j.ccr.2005.10.015 Karetsou, 2009, Identification of distinct SET/TAF-Ibeta domains required for core histone binding and quantitative characterisation of the interaction, BMC Biochem., 10, 10, 10.1186/1471-2091-10-10 Estanyol, 1999, The protein SET regulates the inhibitory effect of p21(Cip1) on cyclin E-cyclin-dependent kinase 2 activity, J. Biol. Chem., 274, 33161, 10.1074/jbc.274.46.33161 Canela, 2003, The SET protein regulates G2/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity, J. Biol. Chem., 278, 1158, 10.1074/jbc.M207497200 Vera, 2006, Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor, Oncogene, 25, 260, 10.1038/sj.onc.1209050 Leopoldino, 2012, SET protein accumulates in HNSCC and contributes to cell survival: antioxidant defense, Akt phosphorylation and AVOs acidification, Oral Oncol., 48, 1106, 10.1016/j.oraloncology.2012.05.014 Almeida, 2012, SET overexpression decreases cell detoxification efficiency: ALDH2 and GSTP1 are downregulated, DDR is impaired and DNA damage accumulates, FEBS J., 279, 4615, 10.1111/febs.12047 Zhou, 2010, Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53, Int. J. Cancer, 126, 395, 10.1002/ijc.24744 Ostareck-Lederer, 2002, C-Src-mediated phosphorylation of hnRNPK drives translational activation of specifically silenced mRNAs, Mol. Cell. Biol., 22, 4535, 10.1128/MCB.22.13.4535-4543.2002 Kwiek, 2006, PITK, a PP1 targeting subunit that modulates the phosphorylation of the transcriptional regulator hnRNPK, Cell. Signal., 18, 1769, 10.1016/j.cellsig.2006.01.019 Iwasaki, 2008, Expression, phosphorylation, and mRNA-binding of heterogeneous nuclear ribonucleoprotein K in Xenopus oocytes, eggs, and early embryos, Dev. Growth Differ., 50, 23, 10.1111/j.1440-169X.2007.00974.x Chen, 2009, Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNPK in nasopharyngeal carcinoma cells, Oncogene, 28, 1904, 10.1038/onc.2009.55 Naro, 2013, Phosphorylation-mediated regulation of alternative splicing in cancer, Int. J. Cell Biol., 2013, 151839, 10.1155/2013/151839 Ro-Choi, 2009, Thermodynamic analyses of the constitutive splicing pathway for ovomucoid pre-mRNA, Mol. Cells, 27, 657, 10.1007/s10059-009-0087-y Lynch, 2005, HnRNPK binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation, Mol. Cell. Biol., 25, 6436, 10.1128/MCB.25.15.6436-6453.2005 Lee, 2012, Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA, Biochem. Biophys. Res. Commun., 420, 467, 10.1016/j.bbrc.2012.03.029